Skip to content

COVID-19 Mortality Prediction Model

Mortality Prediction Model for the Triage of COVID-19, Pneumonia and Mechanically Ventilated ICU Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04358510
Enrollment
114
Registered
2020-04-24
Start date
2020-04-01
Completion date
2020-04-17
Last updated
2020-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Mechanical Ventilation, Pneumonia

Keywords

machine learning, COVID-19, mortality, prediction, pneumonia, mechanical ventilation

Brief summary

The objective of this study is to develop and evaluate an algorithm which accurately predicts mortality in COVID-19, pneumonia and mechanically ventilated ICU patients.

Detailed description

Retrospective study of 53,001 total ICU patients, including 9,166 patients with pneumonia and 25,895 mechanically ventilated patients, performed on the MIMIC dataset. The NPH patient dataset includes 114 patients positive for SARS-COV-2 by PCR test.

Interventions

DEVICECOViage

The COViage machine learning algorithm is designed to predict mortality in COVID-19, pneumonia and mechanically ventilated ICU patients.

Sponsors

Dascena
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years or older * Record of ICU stay

Exclusion criteria

* Patients aged less than 18 years * Patients for which there were no records of raw data or no discharge or death dates.

Design outcomes

Primary

MeasureTime frameDescription
Mortality outcome in COVID-19 ICU patientsThrough study completion, an average of 2 monthsDeceased or not deceased
Mortality outcome in mechanically ventilated ICU patientsThrough study completion, an average of 2 monthsDeceased or not deceased
Mortality outcome in pneumonia ICU patientsThrough study completion, an average of 2 monthsDeceased or not deceased

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026